Symptom Burden in Patients with Malignant Bowel Obstruction Treated With or Without Surgery

被引:2
|
作者
Ayabe, Reed, I [1 ]
Mendoza, Tito [2 ]
Yennu, Sriram [3 ]
Bruera, Eduardo [3 ]
Williams, Loretta A. [2 ]
Badgwell, Brian [1 ,4 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Symptom Res, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Palliat Care Med, Houston, TX USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Unit 1484, 1400 Pressler St, Houston, TX 77030 USA
关键词
PALLIATIVE CARE; ADVANCED CANCER; OUTCOMES; INDICATORS; MANAGEMENT; INPATIENTS; SURVIVAL; SOCIETY;
D O I
10.1097/XCS.0000000000000498
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: Gastrointestinal obstruction is the most common indication for palliative surgical consultation. We sought to assess patient-reported outcomes and survival after surgical and nonsurgical treatment of malignant bowel obstruction.STUDY DESIGN: This was a prospective observational study enrolling patients with advanced malignancy who underwent surgical consultation at a tertiary cancer center. Patient-reported outcomes were evaluated using a previously validated inventory, the MD Anderson Symptom Inventory- Gastrointestinal Obstruction (MDASI-GIO), administered at enrollment and 7 other time points for up to 90 days.RESULTS: We enrolled 125 patients, of whom 37 underwent surgery and 88 did not. Patients treated nonsurgically were more likely to have carcinomatosis on imaging (71% vs 49%, p = 0.02). Pain medicine, palliative care, and chaplaincy consultations occurred in 17%, 30%, and 15% of patients within the first month of enrollment. Higher mean symptom scores were noted by surgical patients, although the only single scores with effect sizes 0.5 or greater were symptom interference with general activity and work. The composite score for interference in work, activity, and walking had the largest effect size at -0.37, indicating greater interference in patients undergoing surgery. Patients selected for surgery had extended overall survival (median 15 vs 3 months, p < 0.01). Carcinomatosis, palliative care evaluation, and venting gastrostomy tube were associated with increased risk of death, and ability to receive subsequent chemotherapy and surgical management were positive prognostic indicators.CONCLUSIONS: In this first study evaluating patient-reported outcomes after treatment for malignant bowel obstruction, we found that selection for surgical treatment was associated with improved survival, but also more symptom interference in general activities and work. These results may be useful in palliative surgical decision-making and informing patients during consultation for malignant bowel obstruction. (J Am Coll Surg 2023;236:514-522. (c) 2022 by the American College of Surgeons. Published by Wolters Kluwer Health, Inc. All rights reserved.)
引用
收藏
页码:514 / 522
页数:9
相关论文
共 50 条
  • [1] SYMPTOM CONTROL IN TERMINALLY ILL PATIENTS WITH MALIGNANT BOWEL OBSTRUCTION (MBO)
    FAINSINGER, RL
    SPACHYNSKI, K
    HANSON, J
    BRUERA, E
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1994, 9 (01) : 12 - 18
  • [2] Symptom burden and lived experiences of patients, caregivers and healthcare professionals on the management of malignant bowel obstruction: A qualitative systematic review
    Baddeley, Elin
    Mann, Mala
    Bravington, Alison
    Johnson, Miriam J.
    Currow, David
    Murtagh, Fliss E. M.
    Boland, Elaine G.
    Obita, George
    Oliver, Alfred
    Seddon, Kathy
    Nelson, Annmarie
    Boland, Jason W.
    Noble, Simon I. R.
    [J]. PALLIATIVE MEDICINE, 2022, 36 (06) : 895 - 911
  • [3] Stent as bridge to surgery in patients with malignant large bowel obstruction
    Cennamo, Vincenzo
    [J]. TECHNIQUES IN GASTROINTESTINAL ENDOSCOPY, 2014, 16 (03) : 119 - 124
  • [4] Outcomes of palliative bowel surgery for malignant bowel obstruction in patients with gynecological malignancy
    Goto, Tomoko
    Takano, Masashi
    Aoyama, Tadashi
    Miyamoto, Morikazu
    Watanabe, Akio
    Kato, Masafumi
    Sasaki, Naoki
    Hirata, Junko
    Sasa, Hidenori
    Furuya, Kenichi
    [J]. ONCOLOGY LETTERS, 2012, 4 (05) : 883 - 888
  • [5] Can malignant bowel obstruction in advanced cancer patients be treated at home?
    Porzio, Giampiero
    Aielli, Federica
    Verna, Lucilla
    Galletti, Brigida
    Shoja e Razavi, Ghazaleh
    Ficorella, Corrado
    [J]. SUPPORTIVE CARE IN CANCER, 2011, 19 (03) : 431 - 433
  • [6] Can malignant bowel obstruction in advanced cancer patients be treated at home?
    Giampiero Porzio
    Federica Aielli
    Lucilla Verna
    Brigida Galletti
    Ghazaleh Shoja e Razavi
    Corrado Ficorella
    [J]. Supportive Care in Cancer, 2011, 19 : 431 - 433
  • [7] Electronic malignant bowel obstruction symptom monitoring smartphone application for patients with gynecologic cancers
    Madariaga, Ainhoa
    Jivraj, Nazlin
    Soberanis Pina, Pamela
    Somji, Faiza
    Truong, Tran
    Melwani, Sheena
    Lovas, Mike
    Gogos, Terri-Ann
    Sajewycz, Katrina
    Bhat, Gita
    Alqaisi, Husam
    Gonzalez-Ochoa, Eduardo
    Veneziani, Ana
    Garg, Vikas
    Dhani, Neesha C.
    Grant, Robert
    Bowering, Valerie
    Oza, Amit M.
    Wang, Lisa
    Berlin, Alejandro
    Lheureux, Stephanie
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024,
  • [8] Racial Disparities in Surgery for Malignant Bowel Obstruction
    Penny, Caitlin L.
    Tanino, Sean M.
    Mosca, Paul J.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (05) : 3122 - 3133
  • [9] Malignant Bowel Obstruction Reappraising the Value of Surgery
    Roses, Robert E.
    Folkert, Ian W.
    Krouse, Robert S.
    [J]. SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2018, 27 (04) : 705 - +
  • [10] The Impact of Treatment on Long-Term Symptom Burden After Malignant Bowel Obstruction From Gastrointestinal Cancer
    Bateni, Sarah
    Law, Calvin
    Barabash, Victoria
    Nalder, Ashlie
    Shariff, Farhana
    Chan, Wing
    Raphael, Michael
    Myrehaug, Sten
    Zeppieri, Jordan
    Coburn, Natalie
    Hallet, Julie
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S222 - S223